摘要
目的探究海藻酸钠微球经子宫动脉栓塞术与子宫肌瘤切除术对多发性子宫肌瘤治疗效果及术后复发情况,为多发性子宫肌瘤的术式选择提供参考。方法分析2014年1月至2015年6月接受治疗的98例多发性子宫肌瘤患者的临床资料。观察组患者46例选择行海藻酸钠微球经子宫动脉栓塞术,对照组患者52例选择行子宫肌瘤切除术。比较两组患者的治疗效果、手术情况、住院时间和复发情况。结果两组患者在总有效率、显效率、有效率、无效率水平比较上,差异均无统计学意义(P>0.05);观察组患者手术时间、术中出血量、住院时间、手术费用及不良反应率明显低于对照组,差异均具有统计学意义(P<0.05);对两组患者术后随访一年发现,观察组患者术后子宫肌瘤复发率明显低于对照组,差异具有统计学意义(6.82%vs.18.75%;Log-rank χ~2=4.660,P=0.031)。结论两种术式对于多发性子宫肌瘤治疗效果相当,而海藻酸钠微球经子宫动脉栓塞术相比子宫肌切除术具有手术时间短、术中出血量较少、住院时间短、手术费用较少、不良反应率低、术后不易复发等优点。
Objective To investigate therapeutic effect and tomy for treatment of muhiple myomata, to provide reference for the with multiple myomata who were treated in our hospital from January prognosis between uterine artetT embolization with KMG and hysteromyomecsurgical methods selection of muhiple myomata. Methods 98 case patients 2014 to June 2015 were enrolled. 46 case patients with uterine artery emboli- zation were selected as observation group, 52 case patients with hysteromyomectomy were selected as control group. Treatment efihct, surgery indi- cators, hospital stay, and surgical recurrence was compared between the two groups of patients receiving different treatment. Results The total el- ficieney rate, effective rate, valid rate, invalid rate in two groups was compared respectively, the difl^renee was not statistically significant （ P 〉 0. 05）. Operation time, intraoperative blood loss, hospitalization time, the operation cost, and adverse reaction rate in observation group were significantly lower than those of the control group, the difference were statistically significant （ P 〈 0. 05 ）. We followed up the two groups patients for one year, recurrence rate of the observation group patients was significantly lower than that of the control group, the difference was statistically significant （6.82% vs. 18,75% ; Log - rank x^2 =4. 660, P =0. 031 ） Conclusion Treatment effect with two kinds of operation methods for multiple myomata are equal. Compared to Hysteromyomectomy, the operation time is shorter, intraoperative blood loss is less, hospitalization time is shorter, operation cost is less, adverse reaction rate is low, recurrence rate is lower in the patients with the Uterine artery embolization with KMB.
出处
《临床和实验医学杂志》
2016年第14期1425-1428,共4页
Journal of Clinical and Experimental Medicine
